Guided Therapeutics, Inc.
USD0.24
+0.00 (+0.00%)
CEO
Mark L. Faupel
IPO Date
2021-01-08
Sector
Healthcare
Industry
Medical - Devices
Exchange
OTC
Country
US
Open
$0.20
Prev. Close
$0.24
Day Low
$0.20
Day High
$0.24
52W Low
$0.12
52W High
$0.54
Market Cap
$0.02B
Volume
0.00M
| -3.6 |
| 31 Dec 2023 | FY | 36.7% | -3560.2% | 91.7% | -209.0% | -0.54 | 0.29 | -2.2 |
| 31 Dec 2022 | FY | -523.1% | -33392.3% | 150.6% | -129.0% | -0.78 | 0.62 | -2.2 |
| 31 Dec 2021 | FY | 24.7% | -2555.6% | 38.0% | -101.5% | -0.53 | 0.29 | -3.7 |
| 31 Dec 2020 | FY | 140.2% | -273.5% | 2.6% | -20.7% | -0.41 | 0.10 | -13.6 |
| 31 Dec 2019 | FY | -94.4% | -5336.1% | 11.3% | -162.8% | -0.36 | 0.08 | -0.6 |
| 31 Dec 2018 | FY | -56.1% | 1782.5% | -6.4% | 430.5% | -0.32 | 0.02 | 0.2 |
| 31 Dec 2017 | FY | -117.2% | -4383.6% | 55.1% | -2187.3% | -0.24 | 0.03 | -0.0 |
| 31 Dec 2016 | FY | 18.5% | -656.2% | 42.8% | -266.1% | -0.44 | 0.11 | -0.0 |
| -7.7 |
| 30 Sept 2025 | Q3 | 13.3% | -1236.7% | 13.1% | -82.2% | -0.43 | 0.12 | -6.6 |
| 30 Jun 2025 | Q2 | 67.5% | -693.2% | 14.8% | -86.3% | -0.41 | 0.13 | -6.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -49.0% | -44.2% | 2.31 | 0.14 | -4.0 |
| 31 Dec 2024 | Q4 | -200.0% | -65200.0% | 13.3% | -47.3% | -0.44 | 0.19 | -3.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 13.3% | -52.4% | -0.48 | 0.17 | -3.8 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 15.2% | -56.7% | -0.48 | 0.18 | -2.0 |
| 31 Mar 2024 | Q1 | 66.7% | -6700.0% | 10.0% | -26.9% | -0.50 | 0.23 | -4.1 |
| 31 Dec 2023 | Q4 | 50.0% | -1206.3% | 10.1% | -23.1% | -0.54 | 0.29 | -5.4 |